Navigation Links
UC San Diego announces collaboration with Johnson & Johnson Pharmaceutical Research & Development
Date:11/20/2008

University of California, San Diego Health Sciences leaders have announced that they have executed a formal Memorandum of Understanding (MOU) with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), with the objective of developing future collaborations in biomedical research and education to advance human health.

The MOU establishes a framework for future research and training efforts between the UC San Diego School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences and the UC San Diego Medical Center health system, and J&JPRD, a pharmaceutical research and development company with expertise in small molecules, genomics, bioinformatics, high throughput screening, and structural biology.

"We are excited about this tremendous opportunity to partner with J&JPRD, which is a world leader in the development of new drugs. This collaboration will further accelerate our efforts at UC San Diego to translate the exciting discoveries being made every day in our laboratories into improved diagnostic and treatment technologies that benefit all patients," said David Brenner, M.D., UC San Diego Vice Chancellor for Health Sciences. "The ability to work more closely with colleagues in the private sector will strengthen our translational research program, and enhance the education of our medical, pharmacy and graduate students, in addition to boosting the potential for new product development."

Brenner joined with G. Diego Miralles, M.D., Head and Chief Medical Officer of J&JPRD's Research and Early Development unit based in San Diego, to sign the MOU in ceremonies at the UC San Diego School of Medicine.

Echoing Dr. Brenner's enthusiasm, Dr. Miralles noted that "academia and industry are natural partners since we have complimentary expertise and share the common goal of addressing unmet medical needs. Working closely with our neighbors at UCSD will help us find win-win opportunities and maximize our com
'/>"/>

Contact: Leslie Franz
lfranz@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1 2

Related medicine news :

1. InVitria to Launch "BE FREE" Promotion at TERMIS '08 in San Diego
2. Centennial Taking Control of Your Diabetes Conference Returns to San Diego to Bring Answers, Advocacy and Hope
3. Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association
4. Car Donations: "Tired Wheels" Turned Into Donation Dollars for Ronald McDonald House Charities, San Diego
5. UC San Diego to lead nationwide program in pharmacogenomics
6. Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego
7. Graves & Thyroid Disease National Patient Conference Set for San Diego, CA
8. Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008
9. Direct From Beijing, 2008 Olympic Gymnastic Superstars and Grammy Award Winning Icons Descend Upon San Diego to Tape ABC Network Womens Cancer Awareness Special, Frosted Pink With A Twist
10. San Diego Supercomputer Center director urges academia to make cyberinfrastructure real
11. CRH Medical Corporation opens Center in San Diego California

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... A new website providing su...lung cancer has been launched at TheFaceofLungCanc...and survivors while distilling important informati... (PRWEB) November 9, 2009 ... public square, and in recognition of November&rsq...
(Date:11/9/2009)... Omnetics Connector Corpora...A systems have been certified. , ...- Omnetics Connector Corporation, the leading manu...ed that their design, production and QA systems ha...& AS9100 Revision B, International Quality System ...
(Date:11/9/2009)..., SAN DIEGO, Nov. 9 HUYA Biosc...,s biopharmaceutical innovation, today announced a... and Pharmacy, Ocean University of China. The agre...t HUYA has established with China,s leading resear...lerate the global development and commercializatio...
(Date:11/9/2009)...A new study finds that women treated for breast ca...ey have dense breasts. Published in the December 1... of the American Cancer Society, the study,s resul... breasts may benefit from additional therapies fol...udies indicate that women with dense breast tissue...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...sued the following statement about the passage of ... and the American voters a lot about core values. ...ore values, seeking to overcome the struggles ordi...les mean that many cannot afford basic healthcare ...
Breaking Medicine News(10 mins):Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 2Health News:The Face of Lung Cancer Support and Information Website Launches to Increase Awareness and Advocacy 3Health News:Omnetics Connector Corporation Achieves AS9100 Certification 2Health News:HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China 2Health News:Breast density associated with increased risk of cancer recurrence 2Health News:Catholics for Choice Statement on Healthcare Reform Bill 2
... CINCINNATIOften, a gentle hand on your shoulder ...d and calm your nerves. , Now, University of Cinc...ccurrence by pairing a complementary therapy known...ques that balance energy for wholeness within a pe...
...ASHINGTON, July 1 Beginning July 6, Sharing,Mirac...am that tells the,compelling and inspirational sto...ympic Gold Medal-winner Greg Louganis. Also on Jul...r Greg Louganis won the hearts of sports fans worl...
... Virginia Commonwealth University and VCU Massey ...e, melanoma differentiation associated gene-7/inte...ct that kills cancer cells not directly receiving ...provide a method to target metastatic disease whi...
...TLANTA, July 1 Children,s Healthcare of Atlanta a...ey are joining forces in the,fight against autism....iary, Marcus Autism Center, which will offer servi...ns who are already serving,the needs of children w...
...USTIN, Texas, July 1 Opus Healthcare Solutions, I...ation systems, has named Ray,Bechtold, CPA, as con...s,Bechtold will be responsible for overseeing all ...cgi-bin/prnh/20080325/LATU040LOGO ), Bechtold joi...
... Providence, RI What began as a college course pr...he first toys of their kind, designed as therapy f...disorder that affects the development of the brain...proving function, however, Karen Kerman, M.D., dir...
Other Medicine News:Health News:Effects of healing touch therapy being studied 2Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 2Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 3Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 4Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 5Health News:'Sharing Miracles' Television Program to Feature Olympic Gold Medal-Winner Greg Louganis 6Health News:Discovery of gene mechanism could bring about new ways to treat metastatic cancer 2Health News:Children's Healthcare of Atlanta to Open Marcus Autism Center 2Health News:Opus Healthcare Solutions Names Ray Bechtold as Controller 2Health News:Toys and technology for rehabilitation in cerebral palsy patients 2Health News:Toys and technology for rehabilitation in cerebral palsy patients 3
(Date:11/6/2009)... 6 Boston Scientific Cor... reached an agreement in principle with the U.S. D...sories issued by its Guidant subsidiary in 2005. ...or to Boston Scientific,s 2006 acquisition of Guid...sed an investigation by the U.S. Attorney,s Office...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Keryx Biopharmaceuticals, ...on Tuesday, November 10, 2009 at 8:30 a.m. EST to ...nd business outlook for the remainder of 2009. Ro... will host the call. Keryx will announce its fina...o be issued prior to the call. ,, In order to p...
(Date:11/6/2009)...Newswire-FirstCall/ -- Caraco Pharmaceutical Labor...rolac tromethamine ophthalmic solution, 0.5% follo...ministration (FDA) for Sun Pharma,s Abbreviated Ne... opthalmic solution on the first day following pat...apeutically equivalent to Acular® Ophthalmic ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 1Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 2Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 3Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 4Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 5Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 6Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 7Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Gly 60041 8UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 1CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 2
...mistry analysis, often conducted in a physicians o...on of a wide array of ailments; UTIs, diabetes, se... and kidney diseases. The estimated global market...llion per year and is growing strongly. For such a...nt clinical procedure, the manufacturers of urinal...
...amonte Content Editor Medcompare.com ,Accor...UNAIDS (Joint United Nations Programme on HIV/AIDS... people living with HIV globally reached an estima... 3 million deaths caused by AIDS. The latest data...ver one million people in the United States are no...
Other Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3
Micro Decker Rongeur
Thin Footplate Kerrison Rongeurs
Synovectomy Rongeur
Husk Rongeurs
Medicine Products: